Page 27 - מדריך תזונה
P. 27

‫מקורות‬

          Allen, J, Gallagher, E, and Mukherjee, R. A Survey of Silent Aspiration in Duchenne Muscular Dystrophy. J Oral Health
          Dent. 2017; 1(S1):A006 Conference Proceeding.
          Cascio, C, Goetze, O, Latshang, T, Bluemel, S, Frauenfelder, T and Bloch, K. Gastrointestinal Dysfunction in Patients with
          Duchenne Muscular Dystrophy. PLoS One. 2016: Oct 13;11(10)
          Gonzalez-Bermejo, J, Lofaso, F, Falaize, L, Lejaille, M, Raphae, J-C, Similowski, T, and Melchior, J-C. Resting energy
          expenditure in Duchenne patients using home mechanical ventilation. Eur Respir J 2005; 25: 682–687
          Lazarus, B, Chen, Y, and Wilson, FP et. al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern
          Med. 2016; 176: 238–246
          Lambert, AA, Lam, JO, Paik, JJ, Ugarte-Gil, C, Drummond, MB, and Crowell, TA. Risk of community-acquired pneumonia
          with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One. 2015; 10: e0128004
          Bushby, K, Finkel, R, Birnkrant, DJ..., and for the DMD Care Considerations Working Group.Diagnosis and management
          of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010; 9: 177–189.
          Birnkrant, David J et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular,
          rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology 2018.
          Birnkrant, David J et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac,
          bone health, and orthopaedic management. The Lancet Neurology 2018.
          Birnkrant, David J et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency
          management, psychosocial care, and transitions of care across the lifespan. The Lancet Neurology 2018.
          Davoodi, J, Markert, CD, Voelker, KA, Hutson, SM, and Grange, RW. Nutrition Strategies to Improve Physical Capabilities
          in Duchenne Muscular Dystrophy. Phys Med Rehabil Clin N Am. 2012 February ; 23(1)
          Kraus, D, Wong, B, Horn, P, Kaul, A. Constipation in Duchenne Muscular Dystrophy: Prevalence, Diagnosis, and
          Treatment. Journal of Pediatrics, April 2016, Volume 171, Pages 183–188.
          Davidson, Z, Rodden, G, Mázala, D, Moore, C, Papillon, C, Hasemann, A, Truby, H and Grange, RW. Practical Nutrition
          Guidelines for Individuals with Duchenne Muscular Dystrophy. Regenerative Medicine for Degenerative Muscle
          Diseases 2015 pp 225-279
          Pessolano, F.A., Suarez, A.A., Monteiro, S.G., Mesa, L., Dubrovsky, A., Roncoroni, A.J. & DeVito, E.L. Nutritional assessment
          of patients with neuromuscular diseases. Am. J. Phys. Med. Rehab. 2003:82, 182–185.
          National Institute for Health and Care Excellence (NICE). Nutrition support for adults: oral nutrition support, enteral
          tube feeding and parenteral nutrition. Clinical guideline [CG32] 2017 (updated). https://www.nice.org.uk/guidance/
          cg32/chapter/1-guidance
          Eckardt, L and Harzer, W. Facial structure and functional findings in patients with progressive muscular dystrophy
          (Duchenne). Am J Orthod Dentofacial Orthop. 1996 Aug;110(2):185-90.
          Symons, AL, Townsend, GC and Hughes, TE. Dental characteristics of patients with Duchenne muscular dystrophy.
          Journal of Dentistry For Children, 2002: September-December.

          Lejaille M,Vaugier I, Orlikowski D,Terzi N, Lofaso F, et al. Noninvasive MechanicalVentilation Improves Breathing-Swallowing
          Interaction of Ventilator Dependent Neuromuscular Patients: A Prospective Crossover Study. PLoS ONE 2016: 11(3)

27
   22   23   24   25   26   27   28